Author: Camilla Giudici

  • Congratulations to Arthur Liesz on being named a Highly Cited Researcher 2026

    The TRR 274 warmly congratulates Arthur Liesz, a valued member of our consortium and PI of project A02, on being recognised as one of the Highly Cited Researchers 2026 by Clarivate. As announced by Ludwig-Maximilians-Universität München (LMU), a record number of 20 LMU researchers have been included in this year’s prestigious international list. The Highly…

  • Laura M. Bartos receives the Felgenhauer Prize

    We are delighted to congratulate Laura M. Bartos, Clinician Scientist in the research group of Prof. Martin Kerschensteiner, PI in our TRR 274, on receiving the prestigious Felgenhauer Prize during the DGN congress 2026. She has been awarded the prize for her outstanding work on “PET imaging of the immune system in multiple sclerosis using…

  • TRR 274 Post Doc Research Awards 2026

    We are delighted to announce Lena Spieth and Matthias Münchhalfen as the recipients of the TRR 274 Postdoctoral Research Awards 2026. Each award provides €10,000 in research funding in recognition of outstanding scientific achievements and to support future research. Lena Spieth is honoured for her outstanding contributions to multiple sclerosis research, particularly the characterization of…

  • Chronic progressive demyelination induces a microglial state with lysosomal dysfunction

    Background Microglia play a central role in removing myelin debris and supporting tissue repair in demyelinating diseases. However, the effects of chronic myelin damage on microglial function remain poorly understood. Aims The study investigated how chronic progressive demyelination affects microglial activation, lysosomal function and lipid metabolism, exploring whether targeting cholesterol metabolism could restore microglial function…

  • Biomedical Neuroscience Microscopy Course 2026

    TRR 274 PhD students Caitlin Gillespie (LMU) and Annika Meilin Schmidke (UMG) participated in an advanced microscopy retreat organized by TRR member Thomas Misgeld (Project B03 and C02) in Berchtesgaden from September 28 to October 2, 2026. The intensive hands-on course brought together researchers for practical training in building both widefield and light-sheet microscopes, as…

  • Anti-CD40L prevents meningeal B cell aggregates and mitigates progressive autoimmune encephalomyelitis

    Background Progressive multiple sclerosis (MS) remains difficult to treat, in part because chronic inflammation persists within the central nervous system (CNS). Meningeal tertiary lymphoid structures (TLS), organised immune-cell aggregates in the meninges, are thought to contribute to sustained neuroinflammation and disease progression. Aims The study investigated whether blocking CD40 ligand (CD40L), a key regulator of…

  • TRR 274 YI Retreat 2026

    TRR 274 Young Invistigator Retreat 2026 in Lohr am Main From 22–24 July 2026, the TRR 274 Young Investigators gathered for their annual retreat in the beautiful surroundings of Lohr am Main. Over two days, early-career researchers presented their latest work and reflected on the progress achieved over the past year through a series of…

  • Network of German Neurocenters @ FENS Forum 2026

    From July 06-10, 2026, TRR 274 was represented at the booth of the Network of German Neuroscience Centers during the Conference of the Federation of European Neuroscience Societies (FENS) in Barcelona, Spain. The Neurocenters in Germany network brings together major neuroscience research centers and funding organizations across the country. Its mission is to promote Germany…

  • ERC Advanced Grant for Martin Kerschensteiner

    Congratulations to our speaker Martin Kerschensteiner on receiving an European Research Council (ERC) Advanced Grant! With his project TACO (Targeting myeloid cell states, actions and interactions in neuroinflammation), Prof. Kerschensteiner aims to unlock multi-omics datasets for the development of more precise, stage- and lesion-specific therapeutic strategies, with potential relevance beyond MS to other neuroinflammatory diseases….

  • Thomas Misgeld Received Membership Certificate from the Leopoldina

    Congratulations to our member Thomas Misgeld, neuroscientist at DZNE’s Munich site, and Director of the Institute of Neuronal Cell Biology at the Technical University of Munich (TUM), that received his membership certificate from the German National Academy of Sciences Leopoldina. This distinction recognizes his outstanding contributions to the neurosciences. Read more about on the DZNE…

  • TRR 274 at Munich Brain Day 2026

    TRR 274 was delighted to support the fourth Munich Brain Day, an event that continues to foster exchange and collaboration within Munich’s vibrant neuroscience community. Among the highlights of this year’s meeting was the presentation by Anna-Sophia Wahl (Project C06), a valued member of the TRR 274 network. The poster session provided an excellent platform…